Comparative Genomics and Proteomics in Drug Discovery

Vol 58
Herausgeber: Parrington, John; Coward, Kevin

• Broschiertes Buch

Produktbeschreibung

Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 164
• Erscheinungstermin: 5. September 2019
• Englisch
• Abmessung: 231mm x 155mm x 13mm
• Gewicht: 272g
• ISBN-13: 9780367389734
• ISBN-10: 0367389738
• Artikelnr.: 57732942

Autorenporträt

John Parrington and Kevin Coward, Department of Pharmacology, University of Oxford, UK.

Inhaltsangabe

1. Comparative Genomics and Drug Discovery in Trypanosomatids 2. The
Practical Implications of Comparative Kinetoplastid Genomics 3. The
Relevance of Host Genes in Malaria 4. Nicotinic Acetylcholine Receptors as
Drug/Chemical Targets, Contributions from Comparative Genomics, Forward and
Reverse Genetics 5. Discovery of Novel Sodium Channel Inhibitors - A Gene
Family-Based Approach 6. 'Omics' in Translational Medicine : Are They Lost
in Translation? 7. Drug-Target Discovery In Silico : Using the Web to
Identify Novel Molecular Targets for Drug Action